38I Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Intellia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 12.1 EUR 5.58% Market Closed

Market Cap: €1.2B

I	Intellia Therapeutics Inc F:38I	US
M	Morgan Stanley F:DWD	US
U	Ubiquiti Inc F:3UB	US
C	Cloudflare Inc XMUN:8CF	US
	Empire Energy Group Ltd ASX:EEG	AU
I	Intuitive Surgical Inc SWB:IUI1	US
	Syros Pharmaceuticals Inc F:0S90	US
C	Coca Cola HBC AG F:C0Q	CH
C	Capital One Financial Corp XBER:CFX	US
C	Campbell Soup Co XHAM:CSC	US
D	Digital Invest eV AG F:ENGL	DE
R	Relx PLC XHAM:RDEB	UK
	Everspin Technologies Inc NASDAQ:MRAM	US
	Mitsui & Co Ltd F:MTS1	JP
	Dufry AG OTC:DFRYF	CH
R	Royal Dutch Shell PLC OTC:RYDAF	NL
K	KGHM Polska Miedz SA XMUN:KGHA	PL
M	Magna International Inc XMUN:MGA	CA
M	Meridian Mining UK Societas F:2MM	UK
S	Synopsys Inc F:SYP	US

Profitability Summary

Intellia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-652%

Negative 3Y Average Operating Margin

-980%

Operating Margin is Increasing

-796% > -652%

Negative Net Margin

-610%

Negative 3Y Average Net Margin

-936%

Net Margin is Increasing

-805% > -610%

Negative Free Cash Flow Margin

-585%

Negative 3Y Average Free Cash Flow Margin

-688%

Free Cash Flow Margin is Increasing

-708% > -585%

Negative ROE

-53%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-141%

ROIC is Increasing

-105% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.